BIO-TECHNE Corp vs Upstart Holdings Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Upstart Holdings Inc trades at $29.3 (market cap $2.76B). The key difference: BIO-TECHNE Corp is far larger — about 4× Upstart Holdings Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals.
| TECH | UPST | |
|---|---|---|
Market Cap | $11.16B | $2.76B |
Sector | Health | Financials |
52-Week High | $72.12 | $84.13 |
52-Week Low | $43.31 | $24.22 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →